J&J Natrecor “Dear Doctor” Letter Advises Against Outpatient Use

Administration of Johnson & Johnson/Scios' Natrecor (nesiritide) in the outpatient setting is an "unsupported use" of the congestive heart failure therapy, the company said in a letter to health care practitioners